Lahore Medical Research Center, LLP

Quick facts

Phase 3 pipeline

• Ibuprofen and Aprepitant · Oncology; Pain Management
  This combination uses ibuprofen to reduce inflammation and pain via COX inhibition, while aprepitant blocks substance P receptors to prevent nausea and vomiting.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Lahore Medical Research Center, LLP portfolio CI brief
• Lahore Medical Research Center, LLP pipeline updates RSS